Kingworld Medicines Group Limited (HKG:1110)
0.465
0.00 (0.00%)
Apr 29, 2026, 3:58 PM HKT
Kingworld Medicines Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 275 | 307 | 270 | 392 | 529 | 473 | Upgrade
|
| Market Cap Growth | -2.65% | 13.61% | -31.19% | -25.88% | 11.84% | 1.33% | Upgrade
|
| Enterprise Value | 532 | 594 | 465 | 522 | 655 | 601 | Upgrade
|
| Last Close Price | 0.47 | 0.52 | 0.43 | 0.56 | 0.74 | 0.62 | Upgrade
|
| PE Ratio | 21.71 | 24.42 | 6.10 | 9.34 | 20.58 | 12.71 | Upgrade
|
| Forward PE | - | 9.16 | 9.16 | 9.16 | 9.16 | 9.16 | Upgrade
|
| PS Ratio | 0.27 | 0.30 | 0.24 | 0.33 | 0.49 | 0.46 | Upgrade
|
| PB Ratio | 0.36 | 0.40 | 0.36 | 0.51 | 0.67 | 0.54 | Upgrade
|
| P/TBV Ratio | 0.47 | 0.52 | 0.46 | 0.67 | 0.89 | 0.75 | Upgrade
|
| P/FCF Ratio | 4.51 | 5.02 | 2.68 | - | 5.03 | 16.85 | Upgrade
|
| P/OCF Ratio | 2.93 | 3.26 | 1.87 | 8.42 | 2.51 | 4.75 | Upgrade
|
| EV/Sales Ratio | 0.52 | 0.58 | 0.41 | 0.44 | 0.61 | 0.58 | Upgrade
|
| EV/EBITDA Ratio | 5.25 | 7.41 | 4.18 | 5.35 | 5.39 | 5.08 | Upgrade
|
| EV/EBIT Ratio | 7.35 | 9.41 | 4.69 | 6.02 | 7.21 | 6.87 | Upgrade
|
| EV/FCF Ratio | 8.70 | 9.72 | 4.61 | - | 6.22 | 21.40 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.63 | 0.57 | 0.51 | 0.42 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 5.25 | 5.25 | 3.55 | 3.59 | 2.45 | 2.25 | Upgrade
|
| Debt / FCF Ratio | 7.90 | 7.90 | 4.25 | - | 3.12 | 10.44 | Upgrade
|
| Net Debt / Equity Ratio | 0.23 | 0.23 | 0.22 | 0.23 | 0.05 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.21 | 2.21 | 1.46 | 1.81 | 0.32 | 0.42 | Upgrade
|
| Net Debt / FCF Ratio | 2.90 | 2.90 | 1.61 | -2.54 | 0.37 | 1.77 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.77 | 0.83 | 0.77 | 0.69 | Upgrade
|
| Inventory Turnover | 5.28 | 5.28 | 6.65 | 7.89 | 7.10 | 4.93 | Upgrade
|
| Quick Ratio | 0.78 | 0.78 | 0.87 | 0.92 | 0.90 | 1.00 | Upgrade
|
| Current Ratio | 1.09 | 1.09 | 1.18 | 1.27 | 1.15 | 1.35 | Upgrade
|
| Return on Equity (ROE) | 5.58% | 5.58% | 10.60% | 8.84% | 6.16% | 7.32% | Upgrade
|
| Return on Assets (ROA) | 2.48% | 2.48% | 4.23% | 3.78% | 4.05% | 3.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.53% | 4.50% | 8.45% | 6.50% | 6.95% | 7.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.50% | 6.50% | 10.30% | 9.00% | 11.10% | 9.60% | Upgrade
|
| Earnings Yield | 4.56% | 4.09% | 16.39% | 10.70% | 4.86% | 7.87% | Upgrade
|
| FCF Yield | 22.18% | 19.93% | 37.36% | -17.77% | 19.88% | 5.94% | Upgrade
|
| Dividend Yield | 6.60% | - | 7.36% | 6.02% | 3.35% | 3.84% | Upgrade
|
| Payout Ratio | 160.84% | 160.84% | 47.60% | 36.54% | 58.45% | 10.89% | Upgrade
|
| Buyback Yield / Dilution | -1.78% | -1.78% | 2.66% | 2.49% | -0.04% | 1.29% | Upgrade
|
| Total Shareholder Return | 4.83% | -1.78% | 10.02% | 8.51% | 3.32% | 5.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.